Double blind, randomized, multicenter controlled trial on Levetiracetam as adjunctive therapy for refractory partial seizures in pediatric epileptic patients
DEC-NET Serial number IT364
Published online08/03/2005 14.37.00
Last updated14/07/2005 16.58.44
Other protocol ID number
Current trial statusPlanned (i.e. not yet recruiting participants)
Major Disease
(ICD9 class)		EPILEPSY UNSPECIFIED
Experimental drug
Levetiracetam
GenderBoth
Age (range)

Eligibility criteria

Trial design/methodology
Phase3
Kind of studyEfficacy
DesignControlled
Randomised
Blinded
Double blind
Principal investigator
NameRoberto Gaggero
InstitutionIstituto G. Gaslini U.O. Neuropsichiatria
Postal addressLargo G. Gaslini 5
City16147 Genova Quarto
CountryITALY
Phone++39 010/5636
Fax
E-mail


Sponsor name
UCB S.A: Pharma Sector (Industry)


Participating countries
MEXICO
CANADA
UNITED STATES
FRANCE
ITALY
UNITED KINGDOM
POLAND
BRAZIL
CZECH REPUBLIC
GERMANY
BELGIUM


Participating centres
Istituto G. Gaslini (Genova)
Fondazione Stella Maris (Calambrone (PI))
Ospedale Fatebenefratelli (Milano)
Ospedale Pediatrico Bambin Gesł (Roma)

ISRCTN  EudraCT  2004-000199-14